0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasma Protein Therapeutics Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-13H13009
Home | Market Reports
Global Plasma Protein Therapeutics Sales Market Report 2023
BUY CHAPTERS

Global Plasma Protein Therapeutics Market Research Report 2026

Code: QYRE-Auto-13H13009
Report
2026-01-23
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plasma Protein Therapeutics Market Size

The global Plasma Protein Therapeutics market was valued at US$ 37750 million in 2025 and is anticipated to reach US$ 62590 million by 2032, at a CAGR of 7.6% from 2026 to 2032.

Plasma Protein Therapeutics Market

Plasma Protein Therapeutics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Plasma Protein Therapeutics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The plasma protein therapeutics market is driven by the increasing prevalence of rare and chronic diseases such as hemophilia, primary immunodeficiency, and autoimmune disorders, which require life-saving plasma-derived treatments. Advances in plasma fractionation techniques and the growing demand for immunoglobulins, albumin, and clotting factors are further fueling market growth. Additionally, improvements in diagnostic technologies have led to earlier detection and treatment of these conditions, expanding the patient pool for plasma protein therapies. Increasing awareness and access to these treatments in developing regions are also contributing to market expansion.A significant challenge in the plasma protein therapeutics market is the limited availability of plasma due to the complex and time-consuming process of plasma collection and fractionation. This often results in supply shortages, which can affect patient access to essential therapies. The high cost of plasma protein therapies, due to the labor-intensive production process and stringent regulatory requirements, also poses a barrier to treatment affordability. Furthermore, the market faces increasing competition from recombinant therapies, which are being developed as alternatives to plasma-derived products, potentially impacting market share.
Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market. North America is the major region of the global market, which takes about 40% market share.
This report delivers a comprehensive overview of the global Plasma Protein Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plasma Protein Therapeutics. The Plasma Protein Therapeutics market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Plasma Protein Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Plasma Protein Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Plasma Protein Therapeutics Market Report

Report Metric Details
Report Name Plasma Protein Therapeutics Market
Accounted market size in 2025 US$ 37750 million
Forecasted market size in 2032 US$ 62590 million
CAGR 7.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Others
by Application
  • Hemophilia
  • PID
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Plasma Protein Therapeutics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Plasma Protein Therapeutics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Plasma Protein Therapeutics Market growing?

Ans: The Plasma Protein Therapeutics Market witnessing a CAGR of 7.6% during the forecast period 2026-2032.

What is the Plasma Protein Therapeutics Market size in 2032?

Ans: The Plasma Protein Therapeutics Market size in 2032 will be US$ 62590 million.

What is the market share of major companies in Plasma Protein Therapeutics Market?

Ans: Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market.

What is the Plasma Protein Therapeutics Market share by region?

Ans: North America is the major region of the global market, which takes about 40% market share.

Who are the main players in the Plasma Protein Therapeutics Market report?

Ans: The main players in the Plasma Protein Therapeutics Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Plasma Protein Therapeutics Market report?

Ans: The Applications covered in the Plasma Protein Therapeutics Market report are Hemophilia, PID, Others

What are the Type segmentation covered in the Plasma Protein Therapeutics Market report?

Ans: The Types covered in the Plasma Protein Therapeutics Market report are Coagulation Factor, Immune Globulin, Albumin, Others

1 Plasma Protein Therapeutics Market Overview
1.1 Product Definition
1.2 Plasma Protein Therapeutics by Type
1.2.1 Global Plasma Protein Therapeutics Market Value by Type: 2025 vs 2032
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Plasma Protein Therapeutics by Application
1.3.1 Global Plasma Protein Therapeutics Market Value by Application: 2025 vs 2032
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Global Plasma Protein Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Plasma Protein Therapeutics Revenue 2021–2032
1.4.2 Global Plasma Protein Therapeutics Sales 2021–2032
1.4.3 Global Plasma Protein Therapeutics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Plasma Protein Therapeutics Market Competition by Manufacturers
2.1 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Plasma Protein Therapeutics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Plasma Protein Therapeutics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Plasma Protein Therapeutics, Product Types and Applications
2.7 Global Key Manufacturers of Plasma Protein Therapeutics, Date of Entry into the Industry
2.8 Global Plasma Protein Therapeutics Market Competitive Situation and Trends
2.8.1 Global Plasma Protein Therapeutics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Plasma Protein Therapeutics Players Market Share by Revenue
2.8.3 Global Plasma Protein Therapeutics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Plasma Protein Therapeutics Market Scenario by Region
3.1 Global Plasma Protein Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Plasma Protein Therapeutics Sales by Region: 2021–2032
3.2.1 Global Plasma Protein Therapeutics Sales by Region: 2021–2026
3.2.2 Global Plasma Protein Therapeutics Sales by Region: 2027–2032
3.3 Global Plasma Protein Therapeutics Revenue by Region: 2021–2032
3.3.1 Global Plasma Protein Therapeutics Revenue by Region: 2021–2026
3.3.2 Global Plasma Protein Therapeutics Revenue by Region: 2027–2032
3.4 North America Plasma Protein Therapeutics Market Facts & Figures by Country
3.4.1 North America Plasma Protein Therapeutics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Plasma Protein Therapeutics Sales by Country (2021–2032)
3.4.3 North America Plasma Protein Therapeutics Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Plasma Protein Therapeutics Market Facts & Figures by Country
3.5.1 Europe Plasma Protein Therapeutics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Plasma Protein Therapeutics Sales by Country (2021–2032)
3.5.3 Europe Plasma Protein Therapeutics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plasma Protein Therapeutics Market Facts & Figures by Region
3.6.1 Asia Pacific Plasma Protein Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Plasma Protein Therapeutics Sales by Region (2021–2032)
3.6.3 Asia Pacific Plasma Protein Therapeutics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Plasma Protein Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Plasma Protein Therapeutics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Plasma Protein Therapeutics Sales by Country (2021–2032)
3.7.3 Latin America Plasma Protein Therapeutics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plasma Protein Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Plasma Protein Therapeutics Sales by Type (2021–2032)
4.1.1 Global Plasma Protein Therapeutics Sales by Type (2021–2026)
4.1.2 Global Plasma Protein Therapeutics Sales by Type (2027–2032)
4.1.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2021–2032)
4.2 Global Plasma Protein Therapeutics Revenue by Type (2021–2032)
4.2.1 Global Plasma Protein Therapeutics Revenue by Type (2021–2026)
4.2.2 Global Plasma Protein Therapeutics Revenue by Type (2027–2032)
4.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2021–2032)
4.3 Global Plasma Protein Therapeutics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Plasma Protein Therapeutics Sales by Application (2021–2032)
5.1.1 Global Plasma Protein Therapeutics Sales by Application (2021–2026)
5.1.2 Global Plasma Protein Therapeutics Sales by Application (2027–2032)
5.1.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2021–2032)
5.2 Global Plasma Protein Therapeutics Revenue by Application (2021–2032)
5.2.1 Global Plasma Protein Therapeutics Revenue by Application (2021–2026)
5.2.2 Global Plasma Protein Therapeutics Revenue by Application (2027–2032)
5.2.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2021–2032)
5.3 Global Plasma Protein Therapeutics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Plasma Protein Therapeutics Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CSL Plasma Protein Therapeutics Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Company Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 LFB Group
6.6.1 LFB Group Company Information
6.6.2 LFB Group Description and Business Overview
6.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
6.6.5 LFB Group Recent Developments/Updates
6.7 Biotest
6.7.1 Biotest Company Information
6.7.2 Biotest Description and Business Overview
6.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biotest Plasma Protein Therapeutics Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 BPL
6.8.1 BPL Company Information
6.8.2 BPL Description and Business Overview
6.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BPL Plasma Protein Therapeutics Product Portfolio
6.8.5 BPL Recent Developments/Updates
6.9 RAAS
6.9.1 RAAS Company Information
6.9.2 RAAS Description and Business Overview
6.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
6.9.5 RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Company Information
6.11.2 Hualan Bio Description and Business Overview
6.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Tiantan Bio
6.12.1 Tiantan Bio Company Information
6.12.2 Tiantan Bio Description and Business Overview
6.12.3 Tiantan Bio Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Tiantan Bio Plasma Protein Therapeutics Product Portfolio
6.12.5 Tiantan Bio Recent Developments/Updates
6.13 Shuanglin Bio
6.13.1 Shuanglin Bio Company Information
6.13.2 Shuanglin Bio Description and Business Overview
6.13.3 Shuanglin Bio Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shuanglin Bio Plasma Protein Therapeutics Product Portfolio
6.13.5 Shuanglin Bio Recent Developments/Updates
6.14 Boya Bio
6.14.1 Boya Bio Company Information
6.14.2 Boya Bio Description and Business Overview
6.14.3 Boya Bio Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Boya Bio Plasma Protein Therapeutics Product Portfolio
6.14.5 Boya Bio Recent Developments/Updates
6.15 Yuanda Shuyang
6.15.1 Yuanda Shuyang Company Information
6.15.2 Yuanda Shuyang Description and Business Overview
6.15.3 Yuanda Shuyang Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Yuanda Shuyang Plasma Protein Therapeutics Product Portfolio
6.15.5 Yuanda Shuyang Recent Developments/Updates
6.16 Weiguang Bio
6.16.1 Weiguang Bio Company Information
6.16.2 Weiguang Bio Description and Business Overview
6.16.3 Weiguang Bio Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Weiguang Bio Plasma Protein Therapeutics Product Portfolio
6.16.5 Weiguang Bio Recent Developments/Updates
6.17 Nanyue Bio
6.17.1 Nanyue Bio Company Information
6.17.2 Nanyue Bio Description and Business Overview
6.17.3 Nanyue Bio Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Nanyue Bio Plasma Protein Therapeutics Product Portfolio
6.17.5 Nanyue Bio Recent Developments/Updates
6.18 KM Biologics
6.18.1 KM Biologics Company Information
6.18.2 KM Biologics Description and Business Overview
6.18.3 KM Biologics Plasma Protein Therapeutics Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 KM Biologics Plasma Protein Therapeutics Product Portfolio
6.18.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plasma Protein Therapeutics Industry Chain Analysis
7.2 Plasma Protein Therapeutics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plasma Protein Therapeutics Production Mode & Process Analysis
7.4 Plasma Protein Therapeutics Sales and Marketing
7.4.1 Plasma Protein Therapeutics Sales Channels
7.4.2 Plasma Protein Therapeutics Distributors
7.5 Plasma Protein Therapeutics Customer Analysis
8 Plasma Protein Therapeutics Market Dynamics
8.1 Plasma Protein Therapeutics Industry Trends
8.2 Plasma Protein Therapeutics Market Drivers
8.3 Plasma Protein Therapeutics Market Challenges
8.4 Plasma Protein Therapeutics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Plasma Protein Therapeutics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Plasma Protein Therapeutics Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Plasma Protein Therapeutics Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Plasma Protein Therapeutics Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Plasma Protein Therapeutics Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Plasma Protein Therapeutics Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Plasma Protein Therapeutics, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Plasma Protein Therapeutics, Product Types and Applications
 Table 12. Global Key Manufacturers of Plasma Protein Therapeutics, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Plasma Protein Therapeutics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Plasma Protein Therapeutics Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Plasma Protein Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Plasma Protein Therapeutics Sales by Region (K Units), 2021–2026
 Table 18. Global Plasma Protein Therapeutics Sales Market Share by Region (2021–2026)
 Table 19. Global Plasma Protein Therapeutics Sales by Region (K Units), 2027–2032
 Table 20. Global Plasma Protein Therapeutics Sales Market Share by Region (2027–2032)
 Table 21. Global Plasma Protein Therapeutics Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Plasma Protein Therapeutics Revenue Market Share by Region (2021–2026)
 Table 23. Global Plasma Protein Therapeutics Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Plasma Protein Therapeutics Revenue Market Share by Region (2027–2032)
 Table 25. North America Plasma Protein Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Plasma Protein Therapeutics Sales by Country (K Units), 2021–2026
 Table 27. North America Plasma Protein Therapeutics Sales by Country (K Units), 2027–2032
 Table 28. North America Plasma Protein Therapeutics Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Plasma Protein Therapeutics Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Plasma Protein Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Plasma Protein Therapeutics Sales by Country (K Units), 2021–2026
 Table 32. Europe Plasma Protein Therapeutics Sales by Country (K Units), 2027–2032
 Table 33. Europe Plasma Protein Therapeutics Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Plasma Protein Therapeutics Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Plasma Protein Therapeutics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Plasma Protein Therapeutics Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Plasma Protein Therapeutics Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Plasma Protein Therapeutics Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Plasma Protein Therapeutics Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Plasma Protein Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Plasma Protein Therapeutics Sales by Country (K Units), 2021–2026
 Table 42. Latin America Plasma Protein Therapeutics Sales by Country (K Units), 2027–2032
 Table 43. Latin America Plasma Protein Therapeutics Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Plasma Protein Therapeutics Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Plasma Protein Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Plasma Protein Therapeutics Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Plasma Protein Therapeutics Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Plasma Protein Therapeutics Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Plasma Protein Therapeutics Sales (K Units) by Type (2021–2026)
 Table 51. Global Plasma Protein Therapeutics Sales (K Units) by Type (2027–2032)
 Table 52. Global Plasma Protein Therapeutics Sales Market Share by Type (2021–2026)
 Table 53. Global Plasma Protein Therapeutics Sales Market Share by Type (2027–2032)
 Table 54. Global Plasma Protein Therapeutics Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Plasma Protein Therapeutics Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Plasma Protein Therapeutics Revenue Market Share by Type (2021–2026)
 Table 57. Global Plasma Protein Therapeutics Revenue Market Share by Type (2027–2032)
 Table 58. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Plasma Protein Therapeutics Sales (K Units) by Application (2021–2026)
 Table 61. Global Plasma Protein Therapeutics Sales (K Units) by Application (2027–2032)
 Table 62. Global Plasma Protein Therapeutics Sales Market Share by Application (2021–2026)
 Table 63. Global Plasma Protein Therapeutics Sales Market Share by Application (2027–2032)
 Table 64. Global Plasma Protein Therapeutics Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Plasma Protein Therapeutics Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Plasma Protein Therapeutics Revenue Market Share by Application (2021–2026)
 Table 67. Global Plasma Protein Therapeutics Revenue Market Share by Application (2027–2032)
 Table 68. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2027–2032)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Takeda Plasma Protein Therapeutics Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. CSL Plasma Protein Therapeutics Product
 Table 79. CSL Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Grifols Plasma Protein Therapeutics Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Octapharma Plasma Protein Therapeutics Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Kedrion Company Information
 Table 91. Kedrion Description and Business Overview
 Table 92. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Kedrion Plasma Protein Therapeutics Product
 Table 94. Kedrion Recent Developments/Updates
 Table 95. LFB Group Company Information
 Table 96. LFB Group Description and Business Overview
 Table 97. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. LFB Group Plasma Protein Therapeutics Product
 Table 99. LFB Group Recent Developments/Updates
 Table 100. Biotest Company Information
 Table 101. Biotest Description and Business Overview
 Table 102. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Biotest Plasma Protein Therapeutics Product
 Table 104. Biotest Recent Developments/Updates
 Table 105. BPL Company Information
 Table 106. BPL Description and Business Overview
 Table 107. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. BPL Plasma Protein Therapeutics Product
 Table 109. BPL Recent Developments/Updates
 Table 110. RAAS Company Information
 Table 111. RAAS Description and Business Overview
 Table 112. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. RAAS Plasma Protein Therapeutics Product
 Table 114. RAAS Recent Developments/Updates
 Table 115. CBPO Company Information
 Table 116. CBPO Description and Business Overview
 Table 117. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. CBPO Plasma Protein Therapeutics Product
 Table 119. CBPO Recent Developments/Updates
 Table 120. Hualan Bio Company Information
 Table 121. Hualan Bio Description and Business Overview
 Table 122. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Hualan Bio Plasma Protein Therapeutics Product
 Table 124. Hualan Bio Recent Developments/Updates
 Table 125. Tiantan Bio Company Information
 Table 126. Tiantan Bio Description and Business Overview
 Table 127. Tiantan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Tiantan Bio Plasma Protein Therapeutics Product
 Table 129. Tiantan Bio Recent Developments/Updates
 Table 130. Shuanglin Bio Company Information
 Table 131. Shuanglin Bio Description and Business Overview
 Table 132. Shuanglin Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Shuanglin Bio Plasma Protein Therapeutics Product
 Table 134. Shuanglin Bio Recent Developments/Updates
 Table 135. Boya Bio Company Information
 Table 136. Boya Bio Description and Business Overview
 Table 137. Boya Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. Boya Bio Plasma Protein Therapeutics Product
 Table 139. Boya Bio Recent Developments/Updates
 Table 140. Yuanda Shuyang Company Information
 Table 141. Yuanda Shuyang Description and Business Overview
 Table 142. Yuanda Shuyang Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. Yuanda Shuyang Plasma Protein Therapeutics Product
 Table 144. Yuanda Shuyang Recent Developments/Updates
 Table 145. Weiguang Bio Company Information
 Table 146. Weiguang Bio Description and Business Overview
 Table 147. Weiguang Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 148. Weiguang Bio Plasma Protein Therapeutics Product
 Table 149. Weiguang Bio Recent Developments/Updates
 Table 150. Nanyue Bio Company Information
 Table 151. Nanyue Bio Description and Business Overview
 Table 152. Nanyue Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 153. Nanyue Bio Plasma Protein Therapeutics Product
 Table 154. Nanyue Bio Recent Developments/Updates
 Table 155. KM Biologics Company Information
 Table 156. KM Biologics Description and Business Overview
 Table 157. KM Biologics Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 158. KM Biologics Plasma Protein Therapeutics Product
 Table 159. KM Biologics Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Plasma Protein Therapeutics Distributors List
 Table 163. Plasma Protein Therapeutics Customers List
 Table 164. Plasma Protein Therapeutics Market Trends
 Table 165. Plasma Protein Therapeutics Market Drivers
 Table 166. Plasma Protein Therapeutics Market Challenges
 Table 167. Plasma Protein Therapeutics Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Plasma Protein Therapeutics
 Figure 2. Global Plasma Protein Therapeutics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Plasma Protein Therapeutics Market Share by Type: 2025 & 2032
 Figure 4. Coagulation Factor Product Picture
 Figure 5. Immune Globulin Product Picture
 Figure 6. Albumin Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Plasma Protein Therapeutics Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Plasma Protein Therapeutics Market Share by Application: 2025 & 2032
 Figure 10. Hemophilia
 Figure 11. PID
 Figure 12. Others
 Figure 13. Global Plasma Protein Therapeutics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Plasma Protein Therapeutics Market Size (US$ Million), 2021–2032
 Figure 15. Global Plasma Protein Therapeutics Sales (K Units), 2021–2032
 Figure 16. Global Plasma Protein Therapeutics Average Price (USD/Unit), 2021–2032
 Figure 17. Plasma Protein Therapeutics Report Years Considered
 Figure 18. Plasma Protein Therapeutics Sales Share by Manufacturers in 2025
 Figure 19. Global Plasma Protein Therapeutics Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Plasma Protein Therapeutics Players: Market Share by Revenue in Plasma Protein Therapeutics in 2025
 Figure 21. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Plasma Protein Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Plasma Protein Therapeutics Sales Market Share by Country (2021–2032)
 Figure 24. North America Plasma Protein Therapeutics Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Plasma Protein Therapeutics Sales Market Share by Country (2021–2032)
 Figure 28. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Plasma Protein Therapeutics Revenue Market Share by Region (2021–2032)
 Figure 36. China Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Taiwan Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Philippines Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Plasma Protein Therapeutics Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Plasma Protein Therapeutics Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Plasma Protein Therapeutics Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. U.A.E Plasma Protein Therapeutics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Plasma Protein Therapeutics by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Plasma Protein Therapeutics by Type (2021–2032)
 Figure 58. Global Plasma Protein Therapeutics Price (USD/Unit) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Plasma Protein Therapeutics by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Plasma Protein Therapeutics by Application (2021–2032)
 Figure 61. Global Plasma Protein Therapeutics Price (USD/Unit) by Application (2021–2032)
 Figure 62. Plasma Protein Therapeutics Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS